Dr. Michelle Rhyu has over twenty years of experience representing life sciences companies, with a primary focus on high-stakes patent, contract and trade secrets disputes in the pharmaceutical and biotechnology industries. She has extensive experience leading litigation and trial teams. Her cases have involved small molecule drug compounds, pharmaceutical formulations, monoclonal antibodies, immunotherapy platform technologies, biofuels, hormone receptors, gene expression technology and medical devices. She has experience with Hatch-Waxman litigation and the abbreviated regulatory pathway for biosimilars (BPCIA).

Download full bio